Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Showing 9 of 0 results

Large-scale testing (Phase 3)UnknownNCT01951469
What this trial is testing

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBrain MetastasesEGFR Mutation
Sun Yat-sen University 160
Testing effectiveness (Phase 2)UnknownNCT01749072
What this trial is testing

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung CancerEffects of Chemotherapy
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)WithdrawnNCT02347839
What this trial is testing

NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.

Who this might be right for
Lung Cancer
Sun Yat-sen University
Large-scale testing (Phase 3)Study completedNCT00242801
What this trial is testing

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

Who this might be right for
NSCLC
AstraZeneca 1,692
Testing effectiveness (Phase 2)Study completedNCT01256437
What this trial is testing

Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash

Who this might be right for
Acneiform Rash
Rabin Medical Center 90
Not applicableEnded earlyNCT02526537
What this trial is testing

Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients

Who this might be right for
NSCLC
Lunxu Liu 10
Testing effectiveness (Phase 2)Study completedNCT00215995
What this trial is testing

Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT00095836
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Who this might be right for
Head and Neck Cancer
Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00193336
What this trial is testing

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation